RecruitingGlenohumeral ArthritisRotator Cuff Arthropathy
Corticosteroid Injection Versus Nerve Block
Eligible age
18–99 yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The purpose of this study is to evaluate conservative pain relief measures for patients suffering from glenohumeral arthritis or rotator cuff arthropathy. Conservative management of osteoarthritis is often first line treatment, and while a corticosteroid injection is frequently used, suprascapular nerve blocks have not often been described as an analgesic option in this population.
Sponsor: University of Minnesota
You may qualify if…
- ✓ diagnosis of glenohumeral osteoarthritis, rheumatoid arthritis, or rotator cuff arthropathy who are being offered injection
You may not qualify if…
- ✕ uncontrolled diabetes (patients will be excluded if no HbA1c within a year or if it is 8 or greater"
- ✕ known allergy to steroid or anesthetic
- ✕ pregnant women
- ✕ prisoners
- ✕ patients with diminished capacity to consent to participation
- ✕ children under 18 years of age
- ✕ non-English speakers
Where it's recruiting
Minnesota
Minneapolis
Source: ClinicalTrials.gov · NCT06735027 · last updated 2026-01-08